| Ytd | -2.97% | |
| 1y | -32.95% |
| Open | 10.61 | Prev Close | 10.61 | Low | 10.61 | High | 11.10 | Mkt Cap | 2.22B |
| Vol | 5.12M | Avg Vol | 5.26M | EPS | -3.15 | P/E | N/A | Forward P/E | 7.17 |
| Beta | 0.91 | Short Ratio | 4.28 | Inst. Own | 110.03% | Dividend | 0.64 | Div Yield | 5.04 |
| Ex Div Date | 12-26 | Earning | 05-05 | 50-d Avg | 10.65 | 200-d Avg | 11.78 | 1yr Est | 13.40 |
XRAY News
This milestone reflects PDS Health's continued investment in digital technologies that help practice
DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY), the world&
In turbulent markets, investors turn to dividend-yielding stocks. Here are analyst ratings for high-
Dentsply Sirona (NASDAQ:XRAY), the world's largest diversified manufacturer of professional dent
Mizuho analyst Steven Valiquette maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and lower
Dentsply Sirona (NASDAQ:XRAY) affirms FY2026 Adj EPS guidance from $1.40-$1.50 to $1.40-$1.50 vs $1.
Dentsply Sirona (NASDAQ:XRAY) reported quarterly earnings of $0.27 per share which missed the analys
Dentsply Sirona (NASDAQ:XRAY), the world's largest diversified manufacturer of professional dent
Citigroup analyst Daniel Grosslight initiates coverage on Dentsply Sirona (NASDAQ:XRAY) with a Se
Dentsply Sirona and Siemens Healthineers are pleased to announce that the first-ever dental-dedicate
Investors turn to dividend-yielding stocks during market turbulence. Benzinga offers latest analyst
Dentsply Sirona (XRAY) reported mixed Q4 results, missing earnings but beating sales estimates. FY20
Mizuho analyst Steven Valiquette maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and raise
Barrington Research analyst Michael Petusky maintains Dentsply Sirona (NASDAQ:XRAY) with a Outper
A sharp banking selloff gripped Wall Street on Friday, compounding a week dominated by concerns over
Autodesk Inc (ADSK) rose sharply after beating Q4 earnings & issuing strong guidance. Other gain
Wells Fargo analyst Vik Chopra maintains Dentsply Sirona (NASDAQ:XRAY) with a Equal-Weight and ra
Evercore ISI Group analyst Elizabeth Anderson maintains Dentsply Sirona (NASDAQ:XRAY) with a In-L
Baird analyst Jeffrey Johnson maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and raises t
Dentsply Sirona (NASDAQ:XRAY) is looking for FY2026 Adj EPS of $1.40-$1.50 vs $1.50 analyst estimate
Dentsply Sirona (NASDAQ:XRAY) reported quarterly earnings of $0.27 per share which missed the analys
As of April 1, Burkhart Dental Supply will represent Dentsply Sirona's full portfolio of dental
B of A Securities analyst Michael Cherny upgrades Dentsply Sirona (NASDAQ:XRAY) from Neutral to B
UBS analyst Kevin Caliendo maintains Dentsply Sirona (NASDAQ:XRAY) with a Buy and lowers the pric
Mizuho analyst Steven Valiquette maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and raise
DENTSPLY SIRONA Inc. ("Dentsply Sirona") (Nasdaq: XRAY), the world's largest diversified
Barrington Research analyst Michael Petusky maintains Dentsply Sirona (NASDAQ:XRAY) with a Outper
Barrington Research analyst Michael Petusky maintains Dentsply Sirona (NASDAQ:XRAY) with a Outper
Baird analyst Jeffrey Johnson maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and lowers t
Barclays analyst Glen Santangelo initiates coverage on Dentsply Sirona (NASDAQ:XRAY) with a Under
Barrington Research analyst Michael Petusky maintains Dentsply Sirona (NASDAQ:XRAY) with a Outper
On November 6, 2025, DENTSPLY SIRONA Inc. (the "Company") filed a Current Report on Form 8-K
JP Morgan analyst Lilia-Celine Lozada maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and
Wells Fargo analyst Vik Chopra maintains Dentsply Sirona (NASDAQ:XRAY) with a Equal-Weight and lo
William Blair analyst Brandon Vazquez downgrades Dentsply Sirona (NASDAQ:XRAY) from Outperform to
Dentsply Sirona stock falls after weak Q3 results, lowered 2025 earnings outlook and CFO exit as CEO